| Modified Glasgow prognostic score, prognostic nutritional index and ECOG performance score predicts survival better than sarcopenia, cachexia and some inflammatory indices in … B Demirelli, NA Babacan, Ö Ercelep, MA Öztürk, S Kaya, E Tanrıkulu, ... Nutrition and cancer 73 (2), 230-238, 2021 | 54 | 2021 |
| Chordoma: a case series and review of the literature O Alan, T Akin Telli, O Ercelep, E Tanrikulu Simsek, T Basoglu Tuylu, ... Journal of Medical Case Reports 12, 1-5, 2018 | 28 | 2018 |
| Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment? O Alan, T Akin Telli, B Aktas, S Koca, IN Ökten, R Hasanov, T Basoglu, ... World Journal of Surgical Oncology 18, 1-9, 2020 | 24 | 2020 |
| Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment A Demir, O Alan, E Oruc World journal of surgical oncology 17, 1-8, 2019 | 19 | 2019 |
| How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature O Alan, O Kuzhan, S Koca, TA Telli, T Basoglu, O Ercelep, D Filinte, ... Journal of Oncology Pharmacy Practice 26 (4), 1011-1018, 2020 | 18 | 2020 |
| A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy O Alan, TA Telli, O Ercelep, R Hasanov, ET Simsek, A Mutis, T Ones, ... Current Problems in Cancer 43 (4), 308-311, 2019 | 14 | 2019 |
| Efficacy and safety of trastuzumab emtansine in HER2 positive metastatic breast cancer: real-world experience A Bahçeci, S Paydaş, N Ak, F Ferhatoğlu, PM Saip, G Seydaoğlu, M Bilici, ... Cancer investigation 39 (6-7), 473-481, 2021 | 11 | 2021 |
| VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: a case series with review of the literature TA Telli, IN Okten, TB Tuylu, NC Demircan, R Arikan, O Alan, O Ercelep, ... Current Problems in Cancer 44 (5), 100568, 2020 | 10 | 2020 |
| Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line … NC Demircan, Ö Alan, T Başoğlu Tüylü, T Akın Telli, R Arıkan, FC Cicek, ... Journal of Oncology Pharmacy Practice 26 (5), 1147-1155, 2020 | 10 | 2020 |
| A rare case of primary rectal choriocarcinoma and review of the literature TA Telli, NC Demircan, O Alan, TB Tuylu, R Arikan, O Ercelep, AE Atıcı, ... Journal of Oncology Pharmacy Practice 26 (4), 989-994, 2020 | 9 | 2020 |
| Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy NC Demircan, F Dane, MA Ozturk, NA Babacan, M Besiroglu, S Kaya, ... Liver 232, 64.4, 2019 | 9 | 2019 |
| Response assessment with molecular characterization of circulating tumor cells and plasma microRNA profiling in patients with locally advanced breast cancer during neoadjuvant … M Akkiprik, S Koca, MÜ Uğurlu, R Ekren, İP Eyüboğlu, Ö Alan, C Erzik, ... Clinical Breast Cancer 20 (4), 332-343. e3, 2020 | 8 | 2020 |
| A case of spontaneous tumor lysis syndrome in extensive-stage small-cell lung cancer: a rare oncologic emergency AM Alan, O Alan Turkish Journal of Emergency Medicine 20 (3), 142-145, 2020 | 8 | 2020 |
| Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer O Ercelep, O Alan, D Sahin, TA Telli, H Salva, TB Tuylu, NA Babacan, ... Clinical and Translational Oncology 21, 499-504, 2019 | 7 | 2019 |
| Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving … TA Telli, S Ozguven, O Alan, N Filizoglu, MA Ozturk, N Sariyar, S Isik, ... Annals of Nuclear Medicine 36 (11), 964-975, 2022 | 6 | 2022 |
| Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma O Ercelep, O Alan, TA Telli, TB Tuylu, R Arıkan, NC Demircan, ET Simsek, ... Tumori Journal 107 (3), 231-237, 2021 | 6 | 2021 |
| Impact of prognostic nutritional index on survival in recurrent glioblastoma O Alan, TA Telli, T Basoğlu, R Arikan, NC Demircan, O Ercelep, M Sakar, ... Neurocirugia (English Edition) 33 (1), 15-21, 2022 | 5 | 2022 |
| Predictive values of systemic inflammation index in prognosis of patients with laryngeal cancer A Demir, O Alan, M Surmeli EJMO 4 (1), 49-53, 2020 | 5 | 2020 |
| Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020–2022) Ç Ünal, G Tunçer, B Çopur, KN Pilanci, KS Okutur, K Yararbaş, Ö Alan, ... Current Medical Research and Opinion 39 (7), 987-996, 2023 | 4 | 2023 |
| Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer İ Yakup, Ç Eyyüp, K Kubilay, A Okan, A Özkan, T Halil, ŞE Selçuk Bratislava Medical Journal-Bratislavske Lekarske Listy, 2022 | 4 | 2022 |
